End stage hip joint disease
Conditions
Interventions
experimental group:Use a protective sleeve for the incision
control group:No protective sleeve is used for the incision
Sponsors
Fujian Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. The diagnosis is consistent with ARCO stage 3~4 of avascular necrosis of the femoral head, congenital hip dysplasia with osteoarthritis (anterior inclination < 40°, Crowe 1, 2), femoral neck fracture, osteoarthritis, rheumatoid arthritis, or ankylosing spondylitis and other lesions caused by severe wear of the hip; 2. Primary total hip replacement; 3. BMI < 30; 4. General anesthesia and surgery contraindications; 5. Signed informed consent; 6. Patients themselves can be effective communication, agree with the artificial joint replacement surgery, good adherence and follow-up on time and inspectors.
Exclusion criteria
Exclusion criteria: (1) revision cases; (2) Severe acetabular dysplasia (Crowe types 3 and 4); (3) Combined with diseases that seriously affect postoperative rehabilitation exercise, such as serious knee diseases, spinal diseases, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| intraoperative muscle damage;creatinine kinase (CK);myoglobin;visual analogue scores;magnitude of changes in the muscle cross-sectional area; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative complications;Forgotten Joint Score;Harris hip score;Patient perceived satisfaction score; | — |
Countries
China
Contacts
Public ContactJie Xu
Fujian Provincial Hospital
Outcome results
None listed